Alphasimplex Group, LLC Laboratory Corp Of America Holdings Transaction History

Alphasimplex Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$213.86 - $277.87 $174,937 - $227,297	-818 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$259.82 - $298.18 $46,247 - $53,076	178 Added 27.81%	818 $216,000
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $173,824 - $201,094	640 New	640 $201,000
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $1.02 Million - $1.15 Million	-3,728 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$204.88 - $255.03 $763,792 - $950,751	3,728 New	3,728 $951,000

128

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.